enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
enVVeno Medical will present its investigational enVVe System at the 38th annual TCT Scientific Symposium in San Diego on November 2, 2026. CEO Rob Berman will deliver the presentation during the Innovation in Endovascular Therapies session, introducing the transcatheter venous valve to a global audience of cardiovascular specialists.
Key figures
- Tct attendees
- 10,000+ physicians, researchers, investors and healthcare leaders
- Dvi us patients estimated
- 3 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.